Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of zanubrutinib added to
standard of care as measured by complete renal response for participants with active
proliferative lupus nephritis